MBX Biosciences, Inc. — Quarterly Balance Sheet (NASDAQ:MBX)

Financials

Total revenue ————— — Gross profit ————— — Operating expenses 19.61 M18.61 M26.53 M21.8 M23.93 M 90.87 M Selling/general/admin expenses 2.87 M3.39 M4.12 M4.08 M4.66 M 16.25 M Research & development 16.75 M15.22 M22.41 M17.73 M19.27 M 74.62 M Operating income 19.61 M18.61 M26.53 M21.8 M23.93 M 90.87 M Non-Operating Income, Total ————— — Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses ————— — Unusual income/expense ————— — Pretax income 19.61 M18.61 M26.53 M21.8 M23.93 M 90.87 M Equity in earnings ————— — Taxes ————— — Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 18.14 M15.59 M23.88 M19.41 M21.62 M 80.5 M Discontinued operations ————— — Net income 18.14 M15.59 M23.88 M19.41 M21.62 M 80.5 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 18.14 M15.59 M23.88 M19.41 M21.62 M 80.5 M Basic earnings per share (Basic EPS) -2.7819.84-0.71-0.58-0.63 17.92 Diluted earnings per share (Diluted EPS) -2.7819.84-0.71-0.58-0.63 17.92 Average basic shares outstanding 3 M10.64 M33.41 M33.43 M33.69 M 111.17 M Diluted shares outstanding 3 M10.64 M33.41 M33.43 M33.69 M 111.17 M EBITDA ————— — EBIT ————— — Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) -487 K-1.45 M-1.24 M-879 K-634 K -4.2 M